{"nct_id":"NCT05070247","title":"A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors","status":"TERMINATED","status_verified_date":"2025-03","start_date":"2022-04-14","start_date_type":"ACTUAL","primary_completion_date":"2025-01-06","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-06","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TAK"]}